Trial
NCT01485094
A Study to Assess the Safety and Efficacy of 7 Days Treatment With a Novel Analgesic in Subjects With Peripheral Neuropathic Pain
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Grünenthal GmbH
Collaborators
—
Condition
Neuralgia
Intervention
GRT6010
Why stopped
The trial was early terminated after it was concluded that there was no added benefit from exposing further participants after an unblinded interim analysis.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-10-28